HIV PROTEASE INHIBITORS

or a pharmaceutically acceptable salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of Formula I, processes for preparing compounds of Formula I, therapeutic methods for treating the proliferation of the HIV virus, treating AIDS or delayin...

Full description

Saved in:
Bibliographic Details
Main Authors McFadden, Ryan, Han, Xiaochun, Xu, Lianhong, Jabri, Salman Y, Qi, Yingmei, Xu, Jie, Yang, Hong, Cai, Zhenhong R, Gonzalez Buenrostro, Ana Zurisadai, Voigt, Johannes, Cho, Aesop
Format Patent
LanguageEnglish
Published 18.03.2021
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:or a pharmaceutically acceptable salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of Formula I, processes for preparing compounds of Formula I, therapeutic methods for treating the proliferation of the HIV virus, treating AIDS or delaying the onset of AIDS symptoms in a mammal using compounds of Formula I.
Bibliography:Application Number: US202016925096